Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
Medical Research Center, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325035, China.
Acta Pharmacol Sin. 2023 Jan;44(1):120-132. doi: 10.1038/s41401-022-00926-2. Epub 2022 Jun 10.
The innate immune response and inflammation contribute to hepatic steatosis and non-alcoholic fatty liver disease (NAFLD). Dectin-1 is a pathogen recognition receptor in innate immunity. In this study, we investigated the role of Dectin-1 in the pathogenesis of NAFLD. We first showed that Dectin-1 expression was significantly elevated in liver tissues of patients with NASH. NAFLD was induced in mice by feeding high fat diet (HFD) for 24 weeks. At the end of treatment, mice were sacrificed, and their blood and liver tissues were collected for analyses. We showed HFD feeding also increased liver Dectin-1 levels in mice, associated with macrophage infiltration. Either gene knockout or co-administration of a Dectin-1 antagonist laminarin (150 mg/kg twice a day, ip, from 16 week to 24 week) largely protected the livers from HFD-induced lipid accumulation, fibrosis, and elaboration of inflammatory responses. In primary mouse peritoneal macrophages (MPMs), challenge with palmitate (PA, 200 μM), an abundant saturated fatty acid found in NAFLD, significantly activated Dectin-1 signaling pathway, followed by transcriptionally regulated production of pro-inflammatory cytokines. Dectin-1 was required for hepatic macrophage activation and inflammatory factor induction. Condition media generated from Dectin-1 deficient macrophages failed to cause hepatocyte lipid accumulation and hepatic stellate activation. In conclusion, this study provides the primary evidence supporting a deleterious role for Dectin-1 in NAFLD through enhancing macrophage pro-inflammatory responses and suggests that it can be targeted to prevent inflammatory NAFLD.
先天免疫反应和炎症导致肝脂肪变性和非酒精性脂肪性肝病(NAFLD)。Dectin-1 是先天免疫中的一种病原体识别受体。在这项研究中,我们研究了 Dectin-1 在 NAFLD 发病机制中的作用。我们首先表明,NASH 患者的肝组织中 Dectin-1 的表达显著升高。通过用高脂肪饮食(HFD)喂养 24 周来诱导 NAFLD。在治疗结束时,处死小鼠,收集其血液和肝脏组织进行分析。我们表明,HFD 喂养也增加了小鼠肝脏中的 Dectin-1 水平,与巨噬细胞浸润有关。要么基因敲除,要么共给予 Dectin-1 拮抗剂岩藻多糖(150mg/kg,每天两次,ip,从 16 周到 24 周),在很大程度上保护肝脏免受 HFD 诱导的脂质积累、纤维化和炎症反应的产生。在原代小鼠腹腔巨噬细胞(MPMs)中,用大量存在于 NAFLD 中的饱和脂肪酸棕榈酸(PA,200μM)刺激,显著激活 Dectin-1 信号通路,随后转录调控产生促炎细胞因子。Dectin-1 是肝脏巨噬细胞激活和炎症因子诱导所必需的。缺乏 Dectin-1 的巨噬细胞产生的条件培养基不能引起肝细胞脂质积累和肝星状细胞激活。总之,这项研究提供了主要证据,表明 Dectin-1 通过增强巨噬细胞的促炎反应在 NAFLD 中起有害作用,并表明可以靶向该受体来预防炎症性 NAFLD。